Adjuvant activity of nocardomycoloyl derivatives of N-acetylmuramyldipeptide in mice and guinea pigs.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000031:analogs & derivatives / Q000276:immunology*; D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000818:Animals; D000970:Antineoplastic Agents / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D005260:Female; D006020:Glycopeptides / Q000276:immunology*; D006168:Guinea Pigs; D006968:Hypersensitivity, Delayed / Q000276:immunology; D051379:Mice; D013601:T-Lymphocytes / Q000276:immunology
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D006020:Glycopeptides; D000119:Acetylmuramyl-Alanyl-Isoglutamine